Halozyme Therapeutics Inc. (HALO) Slipped -6.99% or -1.23 To Price $16.36 On Friday


Halozyme Therapeutics Inc. (HALO) slipped -6.99% or -1.23 to $16.36. It is close to 1.46 million shares traded, which is 178.34% compare to the average total volume 821158. The market cap of HALO is $2.36 billion. The year to date change is -19.91%. The 52 week price range is from $16.06 to $21.48. Price of HALO have changed 2.87% during last week. It have changed 2.39% over last month, 0.46% over last 3 months, -10.12% over last 6 months and -0.73% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for HALO is 17.65. It is 7.89% above current price. The 200-day Moving Averages for HALO is 18.53. It is 13.26% above current price. The 52-week High is 21.48. It is 31.30% from the current price. The 52-week Low is 16.06. It is -1.83% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of HALO is 10.08 on 2018-09-28. Short % to float is 5.95%. There are some statistics of HALO. It is has market cap $2.36 billion. The share outstanding is 144.30 million. The average volume is 821158. The revenue is 253.30M. It has 786.14M cash and 409.20M in debt. The gross profit is 237.48M. The percent of top 15 Institution holding is 90.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of HALO is 48.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of HALO is 18.44%.


Tags:

Share this post